ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
29 hedge funds and large institutions have $3.71M invested in Acorda Therapeutics in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
29
Holding in Top 10
–
Calls
$21K
Puts
$19K
Top Buyers
| 1 | +$115K | |
| 2 | +$9.61K | |
| 3 | +$7.62K | |
| 4 |
HF
HRT Financial
New York
|
+$7K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.66K |
Top Sellers
| 1 | -$332K | |
| 2 | -$26.7K | |
| 3 | -$24.1K | |
| 4 |
UAS
United Asset Strategies
Garden City,
New York
|
-$20.8K |
| 5 |
Millennium Management
New York
|
-$13.4K |